Long-acting β2-agonists in Asthma: Enantioselective safety studies are needed

Glenn A. Jacobson, Sharanne Raidal, Morten Hostrup, Luigino Calzetta, Richard Wood-Baker, Mark O. Farber, Clive P. Page, E. Haydn Walters

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-acting β2-agonists in Asthma: Enantioselective safety studies are needed'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences